1-3 of 3
Bita Esmaeli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Loretta Nastoupil, Paolo Strati, Ranjit Nair, Sairah Ahmed, Raphael E Steiner, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Maria Alma Rodriguez, Fredrick B. Hagemeister, Hun Ju Lee, Michael Wang, Felipe Samaniego, Nathan H. Fowler, Christopher R. Flowers, Lei Feng, Linda Chi, Bita Esmaeli
Journal: Blood
Blood (2021) 138 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2021-154172
Published: 2021
Journal Articles

Rituximab and Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy May Be Feasible Options in Patients with Low-Grade Lymphoma of the Orbit.

Bita Esmaeli, MD, Barbara Pro, MD, M. Wayne Saville, MD, Peter McLaughlin, MD
Journal: Blood
Blood (2005) 106 (11): 4792.
https://doi.org/10.1182/blood.V106.11.4792.4792
Published: 2005
Journal Articles

Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α

Clinical Trials & Observations Brief Report
Fadi Braiteh, Cynthia Boxrud, Bita Esmaeli, Razelle Kurzrock
Journal: Blood
Blood (2005) 106 (9): 2992–2994.
https://doi.org/10.1182/blood-2005-06-2238
Published: 2005